Funding for this research was provided by:
Received: 4 December 2020
Accepted: 27 May 2021
First Online: 7 June 2021
: This study was conducted in accordance with the amended Declaration of Helsinki and approved by the ethics committee at the University of Gothenburg, Sweden, Approval number 501-17, T 820-17 and 1026-15. Written informed consent was obtained from all patients.
: Not applicable.
: KÖ, ZJ, EM and MG are AstraZeneca employees and hold stocks/stock options in AstraZeneca, which supported the study.